EnWave Initiates Transfer of Commercial-Scale powderREV(R) Machine to Major North American Enzyme Producer
18 Fevereiro 2014 - 11:30AM
Marketwired
EnWave Initiates Transfer of Commercial-Scale powderREV(R) Machine
to Major North American Enzyme Producer
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 18, 2014) -
EnWave Corporation (TSX-VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or
the "Company") announced today that the Company has initiated the
transfer of a commercial-scale powderREV® machine (the
"Machinery") to the major North American enzyme producer (the
"Enzyme Producer") who signed a royalty-bearing commercial license
to use Radiant Energy Vacuum ("REV™") technology in April 2013.
Prior to the initiation of the transfer, EnWave completed
successful in-house dehydration trials for several enzyme
solutions.
EnWave will now begin installation of the machine at the Enzyme
Producer's site in preparation for initial testing to begin toward
the beginning of April. Complications relating to the Enzyme
Producer's site preparation delayed the timing of the delivery and
the customer verification work which needs to be completed with
their established Tier 1 customers prior to commercialization. If
the customer verification is successful the Enzyme Producer and
EnWave have now targeted the second half of 2014 for commercial
start-up of the Machinery. The Enzyme Producer is expected to
produce several dehydrated enzymes used in a number of food related
applications and has secured an option for another enzyme category
should the technology successfully meet commercial targets.
powderREV® is designed with the goal of accelerating
the drying times of biomaterials below freezing, while reducing
production costs and maintaining high efficacy of the end product.
Within the existing License Agreement, EnWave has the right to
showcase the commercial powderREV® plant to other
potential licensees in the future. The Enzyme industry is a large
diverse growing global market that produces applications for food
products, detergents, teeth-whitening products, biofuels and other
health improvement areas. The Company hopes to further penetrate
this market after demonstrating initial commercial success.
"The interest in our commercial-scale powderREV®
technology is at an all-time high," stated Dr. Tim Durance,
Chairman & Co-CEO. "We are focused on doing everything in our
power to expedite the start-up process, which when completed will
allow EnWave to showcase the Machinery to other potential
customers."
About EnWave
EnWave Corporation is a Vancouver-based industrial technology
company developing commercial applications for its proprietary
Radiant Energy Vacuum (REV™) dehydration technology. EnWave aims to
sign royalty-bearing commercial licenses with leading food and
pharmaceutical companies for the use of its revolutionary
technology. Thus far the Company has signed commercial licenses
with Bonduelle, a global leader in the production of vegetables,
for the processing of dehydrofrozen vegetables; Hormel Foods
Corporation, a major processed meat manufacturer, for the
production of healthy dried meat products; Milne Fruit Product,
EnWave's first major licensee, for the production of several
dehydrated fruit and vegetable products in the whole, fragmented
and powdered form; a leading North American enzyme company, to
dehydrate a series of food-related enzymes for their Tier 1
clients; and Napa Mountain Spice Company, to dry high-quality
California bay leaves. In addition to these licenses, EnWave has
formed a Limited Liability Partnership with Lucid Capital
Management to develop, manufacture, market and sell all-natural
cheese snack products in the United States under the Moon Cheese®
brand.
Also, EnWave has entered into a wide range of research and
collaboration agreements with an expanding list of multinational
companies, including Nestlé, Kellogg's, Grupo Bimbo, Grimmway
Farms, Ocean Spray Cranberries, Cherry Central, Sun-Maid Growers,
Gay Lea Foods, R.J. Reynolds and Merck. EnWave is introducing REV™
as a new dehydration standard in the food and biological material
sectors: potentially faster and cheaper than freeze drying, with
better end product quality than air drying or spray drying.
EnWave currently has six REV™ platforms: commercial-scale
nutraREV® and MIVAP® are used in the food industry to dry
fruits, vegetables, meat, herbs and seafood quickly and at
low-cost, while maintaining high levels of nutrition, taste,
texture and colour. The Company is also developing
powderREV™ for bulk dehydration of food cultures,
probiotics and fine biochemicals such as enzymes;
quantaREV™ for continuous, high-volume low-temperature
drying of pastes, gels, liquids, or particulates; and
bioREV™ and freezeREV™ as new methods to
stabilize and dehydrate biopharmaceuticals such as vaccines and
antibodies. More information about EnWave is available at
www.enwave.net.
EnWave Corporation
Dr. Tim Durance, Chairman & Co-CEO
Safe Harbour for Forward-Looking Information
Statements: This press release may contain forward-looking
information based on management's expectations, estimates and
projections. All statements that address expectations or
projections about the future, including statements about the
Company's strategy for growth, product development, market
position, expected expenditures, and the expected synergies
following the closing are forward-looking statements. All third
party references to market information in this release are not
guaranteed to be accurate as the Company did not conduct the
original primary research. These statements are not a guarantee of
future performance and involve a number of risks, uncertainties and
assumptions. Although the Company has attempted to identify
important factors that could cause actual results to differ
materially, there may be other factors that cause results not to be
as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
EnWave CorporationMr. John McNicolPresident &
Co-CEO(604)601-8524john.mcnicol@enwave.netEnWave CorporationMr.
Brent CharletonVice President, Corporate
Affairs(778)378-9616bcharleton@enwave.netwww.enwave.net
EnWave (TSXV:ENW)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
EnWave (TSXV:ENW)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024